Pathologica,
Journal Year:
2023,
Volume and Issue:
115(5), P. 284 - 291
Published: Oct. 1, 2023
COVID-19
pandemic
had
affected
health
services
around
the
world,
also
reducing
diagnosis
of
lung
cancer.
On
other
hand,
examination
surgical
specimens
in
patients
with
cancer
and
SARS-CoV-2
gave
opportunity
to
evidence
early
histologic
features
related
this
emerging
pandemic.
Different
prioritization
organizations
during
resulted
a
significant
decline
screening
(up
56%),
delayed
30-40%)
higher
advanced
stage,
some
exceptions
(i.e.,
Canada).
Increased
use
stereotactic
radiation
treatments
stage
I-IIA
have
been
noticed
better-organized
systems.
Surgical
performed
for
incipient
SARSCoV-
2
permitted
appreciate
findings
hyperplastic
pneumocytes
with/without
fibrin
exudate,
alveolar
macrophages/myeloid
cells,
perivascular
T-lymphocytic
infiltrate
lack
hyaline
membrane.
While
has
declined
rate
worldwide,
institutions
significantly
limited
detrimental
effects.
Histology
infection
samples
revealed
specific
changes.
Keep
reading
MedComm,
Journal Year:
2023,
Volume and Issue:
4(5)
Published: Sept. 11, 2023
Abstract
Macrophages
play
diverse
roles
in
development,
homeostasis,
and
immunity.
Accordingly,
the
dysfunction
of
macrophages
is
involved
occurrence
progression
various
diseases,
such
as
coronavirus
disease
2019
atherosclerosis.
The
protective
or
pathogenic
effect
that
exert
different
conditions
largely
depends
on
their
functional
plasticity,
which
regulated
via
signal
transduction
Janus
kinase–signal
transducer
activator
transcription,
Wnt
Notch
pathways,
stimulated
by
environmental
cues.
Over
past
few
decades,
molecular
mechanisms
signaling
pathways
have
been
gradually
elucidated,
providing
more
alternative
therapeutic
targets
for
diseases
treatment.
Here,
we
provide
an
overview
basic
physiology
expound
regulatory
within
them.
We
also
address
crucial
role
pathogenesis
including
autoimmune,
neurodegenerative,
metabolic,
infectious
cancer,
with
a
focus
advances
macrophage‐targeted
strategies
exploring
modulation
components
regulators
pathways.
Last,
discuss
challenges
possible
solutions
therapy
clinical
applications.
hope
this
comprehensive
review
will
directions
further
research
targeting
macrophage
are
promising
to
improve
efficacy
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(4), P. 873 - 873
Published: April 20, 2023
The
COVID-19
pandemic
is
a
severe
concern
worldwide,
particularly
in
Africa.
Vaccines
are
crucial
the
fight
against
pandemic.
This
scoping
review
examined
existing
literature
from
2020
to
2022
on
individual,
interpersonal,
and
structural
barriers
facilitators
vaccination
within
Africa
facilitate
more
informed
health
promotion
interventions
improve
vaccine
uptake.
was
conducted
using
Arksey
O’Malley’s
five-stage
methodological
framework.
A
comprehensive
search
undertaken
2021
six
electronic
databases:
EBSCOhost,
PubMed,
Web
of
Science,
ProQuest,
WorldCat
Discovery,
Google
Scholar.
Data
collected,
charted
into
themes,
summarized
standard
data
extraction
sheet
Microsoft
Excel.
total
forty
(n
=
40)
published
academic
articles
were
reviewed,
with
many
Nigeria
10),
followed
by
Ethiopia
5)
Ghana
4)
rest
elsewhere
Thematic
narratives
used
report
themes:
attitudes
perceptions
about
vaccines,
intention
uptake
vaccines;
factors
associated
uptake;
socio-demographic
determinants
affecting
information
sources
for
vaccines.
ranged
25%
80.9%,
resulting
suboptimal
rate
(54.2%)
African
continent.
Factors
that
promoted
acceptance
included
confidence
vaccines
desire
protect
people.
Age,
education,
gender
most
common
significantly
acceptance.
Most
studies
revealed
considerable
exist
Concerns
potential
side
effects,
ineffectiveness,
perceived
lack
information,
inaccessibility
among
unwillingness
receive
strongly
correlated
being
female.
Mass
social
media
main
regarding
To
encourage
uptake,
governments
should
pay
attention
refuting
misinformation
through
integrated
community-based
approaches,
such
as
creating
messages
convey
than
just
information.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(11), P. 2582 - 2582
Published: Nov. 3, 2023
Airway
mucus
dysfunction
and
impaired
immunological
defenses
are
hallmarks
of
several
lung
diseases,
including
asthma,
cystic
fibrosis,
chronic
obstructive
pulmonary
mostly
causative
factors
in
bacterial-biofilm-associated
respiratory
tract
infections.
Bacteria
residing
within
the
biofilm
architecture
pose
a
complex
challenge
clinical
settings
due
to
their
increased
tolerance
currently
available
antibiotics
host
immune
responses,
resulting
infections
with
high
recalcitrance
rates
morbidity
mortality.
To
address
these
unmet
needs,
potential
anti-biofilm
therapeutic
strategies
being
developed
effectively
control
bacterial
biofilm.
This
review
focuses
on
recent
advances
development
application
nanoparticulate
drug
delivery
systems
for
treatment
biofilm-associated
infections,
especially
addressing
barriers
concern
accessibility
various
types
nanoparticles
used
combat
biofilms.
Understanding
obstacles
facing
biofilms
nanoparticle-based
approaches
combatting
may
encourage
researchers
explore
promising
modalities
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(23), P. 7245 - 7245
Published: Nov. 23, 2023
COVID-19,
caused
by
the
SARS-CoV-2
virus,
has
revealed
a
complex
interplay
between
inflammation
and
coagulation,
leading
to
emergence
of
concept
thrombo-inflammation.
This
recognizes
that
COVID-19
is
not
solely
respiratory
illness,
but
systemic
disease
with
significant
vascular
hematological
components.
associated
an
unusual
prothrombotic
state,
intense
endothelial
activation
vasculopathy,
cytokine
storm,
complement
system
hypercoagulability
state
(the
platelets
coagulation
cascade,
impaired
fibrinolysis).
The
aim
this
review
discuss
different
pathological
pathways
described
in
lead
thromboembolic
events.
Widespread
vaccination
post-COVID-19
immunization
allows
control
over
severity
pandemic.
A
better
understanding
pathophysiology
can
improve
management
frail
patients
who
are
hospitalized
intensive
care
units.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(5), P. 1397 - 1397
Published: Feb. 28, 2024
First
described
in
December
2019
Wuhan
(China),
COVID-19
disease
rapidly
spread
worldwide,
constituting
the
biggest
pandemic
last
100
years.
Even
if
SARS-CoV-2,
agent
responsible
for
COVID-19,
is
mainly
associated
with
pulmonary
injury,
evidence
growing
that
this
virus
can
affect
many
organs,
including
heart
and
vascular
endothelial
cells,
cause
haemostasis,
CNS,
kidney
gastrointestinal
tract
abnormalities
impact
course
prognosis.
In
fact,
may
almost
all
organs.
Hence,
SARS-CoV-2
essentially
a
systemic
infection
present
large
number
of
clinical
manifestations,
it
variable
distribution
severity,
which
means
potentially
life-threatening.
The
goal
comprehensive
review
paper
series
to
give
an
overview
non-pulmonary
involvement
special
focus
on
underlying
pathophysiological
mechanisms
presentation.
Virology Journal,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: April 23, 2024
Abstract
Background
This
study
sought
to
examine
the
impact
of
magnesium
supplementation
on
clinical
outcomes
and
biochemical
factors
among
hospitalized
patients
with
COVID-19.
Methods
double-blind,
randomized
trial
was
conducted
at
Razi
Hospital,
Ahvaz,
Iran,
between
September
2021
March
2022.
Participants
aged
18–70
years
moderate
disease
severity
were
enrolled.
Magnesium
(300
mg
daily)
administered
intervention
group,
while
control
group
received
a
placebo.
Clinical
outcomes,
including
need
for
oxygen
therapy,
saturation,
respiratory
rate,
fever,
hs-CRP
TNF-α
levels,
as
well
quality
life
mental
health,
assessed.
Blood
samples
collected
measure
variables.
Results
The
main
result
count
individuals
requiring
therapy.
Additional
comprised
health.
Out
64
participants,
60
completed
study.
results
showed
that
significantly
reduced
number
therapy
(9
vs.
14;
P
<
0.001).
Moreover,
demonstrated
improved
saturation
compared
(4.55
±
2.35
1.8
1.67;
Furthermore,
we
observed
noteworthy
enhancement
in
depression
score
group.
No
significant
differences
hs-CRP,
levels
(
>
0.05).
Conclusion
findings
suggest
may
have
beneficial
effects
arterial
COVID-19
patients.
More
investigation
is
necessary
delve
into
its
potential
mechanisms
long-term
patient
outcomes.
Trial
registration
registered
Iranian
Registry
Trials
(IRCT)
under
identifier
IRCT20210413050957N1.
(The
date:
May
1,
2021).
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
129, P. 111600 - 111600
Published: Feb. 6, 2024
Understanding
the
relationship
between
patient
immune
characteristics,
disease
severity,
and
mortality
represents
a
critical
step
in
fight
against
COVID-19.
Elevated
levels
of
programmed
death
ligand-1
(PD-L1)
Neutrophil-lymphocyte
ratio
(NLR)
are
linked
to
increased
severity
acute
COVID-19
patients.
This
study
aimed
investigate
association
combination
sPD-L1
NLR
with
1-year
Mortality
patients
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Introduction:
Polymorphonuclear
neutrophils
(PMN)
are
actively
recruited
during
COVID-19
and
yet
dysfunctions
associated
with
its
prognosis.
The
PMN
receptor
CXCR4
ligand
SDF-1/CXCL12
known
to
play
a
role
in
the
recruitment
of
PMN.
primary
objective
was
evaluate
modulation
this
pathway
patients
after
treatment
dexamethasone
(DXM).
Secondary
objectives
were
miRNA
expression
profiles.
Material
Methods
We
conducted
prospective
study
comparing
admitted
emergency
department
from
December
2022
April
2023
for
SARS-CoV-2
infection
control
population.
studied
surface
receptor,
circulating
levels
SDF-1
miR
levels.
Patients
treated
(DXM)
sampled
again
at
H48.
Results
Forty-four
infected
20
controls
analyzed.
significantly
increased
decreased
by
DXM
+
percentages
significantly.
on
admission
risk
mechanical
ventilation.
Levels
15b-5p,
146a-5p,
155-5p
30d-5p
patients.
miR-hsa-122
found
mortality
variation
need
Conclusions
Our
suggests
possible
involvement
SDF-1/CXCR4
axis
physiopathogenesis
COVID-19.
Chaos An Interdisciplinary Journal of Nonlinear Science,
Journal Year:
2025,
Volume and Issue:
35(2)
Published: Feb. 1, 2025
The
post-acute
sequelae
of
COVID-19
(PASC)
poses
a
significant
health
challenge
in
the
post-pandemic
world.
However,
underlying
biological
mechanisms
PASC
remain
intricate
and
elusive.
Network-based
methods
can
leverage
electronic
record
data
knowledge
to
investigate
impact
on
uncover
mechanisms.
This
study
analyzed
territory-wide
longitudinal
records
(from
January
1,
2020
August
31,
2022)
50
296
patients
healthy
non-exposed
group
100
592
individuals
determine
disease
progression,
provide
molecular
insights,
identify
associated
biomarkers.
We
constructed
comorbidity
network
performed
disease-protein
mapping
protein-protein
interaction
analysis
reveal
trajectories.
Results
showed
disparities
prevalent
patterns,
with
certain
patterns
exhibiting
more
pronounced
influence
by
COVID-19.
Overlapping
proteins
elucidate
COVID-19's
each
pattern,
essential
be
identified
based
their
weights.
Our
findings
help
clarify
COVID-19,
discover
intervention
methods,
decode
basis
associations,
while
also
yielding
potential
biomarkers
corresponding
treatments
for
specific
progression
patterns.